Summary

Liquid Biopsy, CTC, Circulating Tumor Cell, Personalized Medicine, Companion Diagnostic, Diagnostics, Therapeutics, Oncology, Metastatic

Industry

Description

TellBio Inc. is a development stage biotechnology company with the goal to revolutionize the detection and treatment of cancer through its unique and proprietary circulating tumor cells (CTCs) technology and complementary therapeutics platform, TellDx and TellRx, respectively. TellBio’s vision is to free patients and their families from the tyranny of cancer via both its TellDx and TellRx platforms. The foundation of the Company’s approach – detection of and targeting CTCs – is exclusively licensed from Massachusetts General Hospital and is based on decades of academic and clinical research.

Profile

  • Incorporated in
    Delaware
  • Established since
    2019
  • Main/Branch
    Branch

Address